Breaking News
December 17, 2018 - How the Mediterranean Diet Can Help Women’s Hearts
December 17, 2018 - Sustained connections associated with symptoms of autism
December 17, 2018 - Concussion rates among young football players were higher than previously reported
December 17, 2018 - Cresco Labs granted approval to operate marijuana dispensary in Ohio
December 17, 2018 - Study provides insight into health risks facing new mothers
December 17, 2018 - AMSBIO expands Wnt signaling pathway product range to aid research
December 16, 2018 - Surgical treatment unnecessary for many prostate cancer patients
December 16, 2018 - Excess weight responsible for cancers globally finds report
December 16, 2018 - Regular sex associated with greater enjoyment of life in seniors
December 16, 2018 - Social stigma contributes to poor mental health in the autistic community
December 16, 2018 - Multidisciplinary team successfully performs complex surgery on patient suffering from enlarged skull
December 16, 2018 - Experts analyze data that can guide antidepressant discontinuation
December 16, 2018 - Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
December 16, 2018 - Siblings of children with autism or ADHD are at elevated risk for both disorders
December 16, 2018 - New project aims to understand why and how metabolic disorders develop in patients
December 16, 2018 - Diets containing GM maize have no harmful effects on health or metabolism of rats
December 16, 2018 - Are doctors and teachers confusing immaturity and attention deficit?
December 16, 2018 - Hearing loss linked with increased risk for premature death
December 16, 2018 - Chromatrap buffer reagents for lysing cells offer many benefits
December 16, 2018 - Young Breast Cancer Patients Face Higher Risk for Osteoporosis
December 16, 2018 - 3-D printing offers helping hand to people with arthritis
December 16, 2018 - Community Health Choice helps manage complex and chronic care conditions
December 16, 2018 - Regular trips out could dramatically reduce depression in older age
December 16, 2018 - CWRU to use VivaLNK’s Vital Scout device for stress study in student athletes
December 16, 2018 - ‘Easy Way Out’? Stigma May Keep Many From Weight Loss Surgery
December 16, 2018 - Gout drug may protect against chronic kidney disease
December 16, 2018 - Talking about memories enhances the wellbeing of older and younger people
December 16, 2018 - Occupational exposure to pesticides increases risk for cardiovascular disease among Latinos
December 16, 2018 - A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning
December 16, 2018 - Magnesium may play important role in optimizing vitamin D levels, study shows
December 16, 2018 - The effect of probiotics on intestinal flora of premature babies
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
December 15, 2018 - Lifespan extension at low temperatures depends on individual’s genes, study shows
December 15, 2018 - New ingestible capsule can be controlled using Bluetooth wireless technology
December 15, 2018 - Researchers uncover microRNAs involved in the control of social behavior
December 15, 2018 - Research offers hope for patients with serious bone marrow cancer
December 15, 2018 - Link between poverty and obesity is only about 30 years old, study shows
December 15, 2018 - Mass spectrometry throws light on old case of intentional heavy metal poisoning
December 15, 2018 - BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
December 15, 2018 - Study finds that in treating obesity, one size does not fit all
December 15, 2018 - Tenacity and flexibility help maintain psychological well-being, mobility in older people
December 15, 2018 - Study reveals role of brain mechanism in memory recall
December 15, 2018 - High levels of oxygen encourage the brain to remain in deep, restorative sleep
December 15, 2018 - Experimental HIV vaccine strategy works in non-human primates, research shows
December 15, 2018 - Genetically modified pigs could limit replication of classical swine fever virus, study shows
December 15, 2018 - FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 15, 2018 - Cost and weight-loss potential matter most to bariatric surgery patients
December 15, 2018 - Cancer Research UK and AstraZeneca open new Functional Genomics Centre
December 15, 2018 - New research lays out potential path for treatment of Huntington’s disease
December 15, 2018 - Prestigious R&D 100 Award presented to Leica Microsystems
December 15, 2018 - Study shows septin proteins detect and kill gut pathogen, Shigella
December 15, 2018 - Study sheds new light on disease-spreading mosquitoes
December 15, 2018 - 2017 Saw Slowing in National Health Care Spending
December 15, 2018 - Monitoring movement reflects efficacy of mandibular splint
December 15, 2018 - Study supports BMI as useful tool for assessing obesity and health
December 15, 2018 - Self-guided, internet-based therapy platforms effectively reduce depression
December 15, 2018 - Organically farmed food has bigger climate impact than conventional food production

Drug-Resistant Bacteria: On the Edge of a Crisis

image_pdfDownload PDFimage_print

Drug-Resistant Bacteria: On the Edge of a Crisis

Photo: iStock

For the past 70 years, antimicrobial drugs, such as antibiotics, have successfully treated patients with infections. But over time, many infectious organisms have adapted to the drugs that kill them, making them less e ective. Overusing or misusing these drugs can make resistance develop even faster.

Each year in the U.S. at least 2 million people become infected with bacteria that are resistant to antibiotics. At least 23,000 people die annually as a direct result of these infections. Many more people die from complications of antibiotic-resistant infections.

To address this growing problem, the National Institute of Allergy and Infectious Diseases (NIAID) is working to speed the development of faster ways to detect resistance and ultimately to nd new treatments that are e ective against these drug-resistant bacteria.

Anthony S. Fauci, M.D., has been the director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984. He helped pioneer the field of human immunoregulation, or the control of specific immune responses and interactions. He has also advised five presidents and the U.S. Department of Health and Human Services on HIV/AIDS and many other health issues. He spoke to NIH MedlinePlus magazine to discuss NIAID’s drug-resistant bacteria research program.

Why are certain bacteria becoming more resistant to drugs?

There is a multi-part answer to that question. One of the most important reasons is that bacteria generally mutate—all microbes mutate—naturally and spontaneously. However, you can do things that pressure them to mutate even more and develop resistance to drugs.

Each year in the U.S., at least 2 million people become infected with bacteria that are resistant to antibiotics
– Centers for Disease Control and Prevention

One of the major factors in certain bacteria becoming resistant to drugs today is the overuse of antibiotics, particularly the inappropriate use of antibiotics. This includes using antibiotics when you do not really have to—either when you have a viral infection that you think is bacterial and treat it with an antibiotic, or you treat someone with the wrong antibiotic that is not particularly suited to the bacteria in question.

In other words, if you are given antibiotics, you will kill all the sensitive bacteria. Most of the ones that will survive will be the resistant ones.

You and other experts in the field have said that we are on the edge of a national, even global crisis of drug-resistant bacteria. Why is that?

The more we see this growing problem of antimicrobial resistance throughout the world, the more we will begin to see bacteria that are relatively untreatable or very, very difficult to treat. And if those bacteria become very widespread, that could lead to a serious crisis.

What might such a situation look like to most people?

A typical, real-life example would be someone gets a surgical procedure like a hip or knee replacement, or goes to the hospital for abdominal surgery. Then they get an infection that happens to come from another hospital patient who has resistant bacteria. What should be a routine procedure could lead to an infection that you struggle to treat, and you end up with a high degree of morbidity or even mortality. The routine surgical case becomes a medical emergency.

What kinds of antimicrobial-resistant bacteria are common in the U.S.?

We still have the problem of methicillin-resistant Staphylococcus aureus (MRSA), which is disturbing. Another one that is also disturbing is called Carbapenem-resistant Enterobacteriaceae, or CRE. That is a growing problem. We see that in hospital patients who are immunosuppressed as a result of, for example, transplants or drugs that suppress their cancer or their inflammatory disease. Another bacteria that causes infections when antibiotics are overused is Clostridium difficile (C. Difficile), which we see a lot of in nursing homes and hospital settings.

Those three are big ones—MRSA, CRE, and C. Difficile. And, depending on the population in question, globally we are seeing more and more resistance to gonorrhea, a sexually transmitted disease.

How is NIAID approaching research to help solve the challenges associated with antimicrobial resistance?

Our research spans a wide range of activities, starting with understanding the molecular basis of how bacterial resistance evolves.

The second thing we are doing is a molecular analysis of microbes to determine what the targets are for resistance and for new antibiotics. Another is to develop new, unique ways of combating bacteria, such as understanding how microbes survive in different environments and exploiting that to fight them.

We also spend a lot of time working with the pharmaceutical companies on concept development towards the ultimate development of new antibiotics. While new antibiotics will ultimately be made by pharmaceutical companies, NIH and NIAID have a basic, fundamental role in the clinical and applied research and development of these new antibiotics.

Tagged with:

About author

Related Articles